Skip to main content
Image placeholder title

Here's a chart depicting the most current obesity drug market share. The trend is undeniable: Orexigen Therapeuticsundefined is gaining, Arena Pharma (ARNA) and Vivusundefined are falling. 

Source: IMS Health via J.P. Morgan.

Adam Feuerstein writes regularly for TheStreet. In keeping with company editorial policy, he doesn't own or short individual stocks, although he owns stock in TheStreet. He also doesn't invest in hedge funds or other private investment partnerships. Feuerstein appreciates your feedback;

click here

to send him an email.